메뉴 건너뛰기




Volumn 7, Issue 8, 2018, Pages

Molecular targets in hepatocarcinogenesis and implications for therapy

Author keywords

Hepatocarcinogenesis; Inflammasome; Liver cancer; NF B

Indexed keywords

BEVACIZUMAB; BORTEZOMIB; EVEROLIMUS; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA; TICILIMUMAB; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

EID: 85067470086     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm7080213     Document Type: Review
Times cited : (29)

References (202)
  • 1
    • 84955299344 scopus 로고    scopus 로고
    • Global cancer incidence and mortality rates and trends—An update
    • Torre, L.A.; Siegel, R.L.; Ward, E.M.; Jemal, A. Global cancer incidence and mortality rates and trends—An update. Cancer Epidemiol. Biomark. Prev. 2016, 25, 16–27. [CrossRef] [PubMed]
    • (2016) Cancer Epidemiol. Biomark. Prev. , vol.25 , pp. 16-27
    • Torre, L.A.1    Siegel, R.L.2    Ward, E.M.3    Jemal, A.4
  • 2
    • 7044264264 scopus 로고    scopus 로고
    • Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study
    • Davila, J.A.; Morgan, R.O.; Shaib, Y.; McGlynn, K.A.; El-Serag, H.B. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study. Gastroenterology 2004, 127, 1372–1380. [CrossRef] [PubMed]
    • (2004) Gastroenterology , vol.127 , pp. 1372-1380
    • Davila, J.A.1    Morgan, R.O.2    Shaib, Y.3    McGlynn, K.A.4    El-Serag, H.B.5
  • 4
    • 0023933449 scopus 로고
    • Hepatitis B virus. The major etiology of hepatocellular carcinoma
    • Beasley, R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988, 61, 1942–1956. [CrossRef]
    • (1988) Cancer , vol.61 , pp. 1942-1956
    • Beasley, R.P.1
  • 5
    • 0028818446 scopus 로고
    • Primary prevention of hepatocellular carcinoma
    • Yu, S.Z. Primary prevention of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1995, 10, 674–682. [CrossRef] [PubMed]
    • (1995) J. Gastroenterol. Hepatol. , vol.10 , pp. 674-682
    • Yu, S.Z.1
  • 6
    • 0031914318 scopus 로고    scopus 로고
    • Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice
    • Ghebranious, N.; Sell, S. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice. Hepatology 1998, 27, 383–391. [CrossRef] [PubMed]
    • (1998) Hepatology , vol.27 , pp. 383-391
    • Ghebranious, N.1    Sell, S.2
  • 8
    • 0035793805 scopus 로고    scopus 로고
    • Betel quid chewing as a risk factor for hepatocellular carcinoma: A case-control study
    • Tsai, J.F.; Chuang, L.Y.; Jeng, J.E.; Ho, M.S.; Hsieh, M.Y.; Lin, Z.Y.; Wang, L.Y. Betel quid chewing as a risk factor for hepatocellular carcinoma: A case-control study. Br. J. Cancer 2001, 84, 709–713. [CrossRef] [PubMed]
    • (2001) Br. J. Cancer , vol.84 , pp. 709-713
    • Tsai, J.F.1    Chuang, L.Y.2    Jeng, J.E.3    Ho, M.S.4    Hsieh, M.Y.5    Lin, Z.Y.6    Wang, L.Y.7
  • 9
    • 85019705576 scopus 로고    scopus 로고
    • Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers
    • Chu, Y.J.; Yang, H.I.; Wu, H.C.; Liu, J.; Wang, L.Y.; Lu, S.N.; Lee, M.H.; Jen, C.L.; You, S.L.; Santella, R.M.; et al. Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers. Int. J. Cancer 2017, 141, 711–720. [CrossRef] [PubMed]
    • (2017) Int. J. Cancer , vol.141 , pp. 711-720
    • Chu, Y.J.1    Yang, H.I.2    Wu, H.C.3    Liu, J.4    Wang, L.Y.5    Lu, S.N.6    Lee, M.H.7    Jen, C.L.8    You, S.L.9    Santella, R.M.10
  • 10
    • 0025828517 scopus 로고
    • Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
    • Bressac, B.; Kew, M.; Wands, J.; Ozturk, M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991, 350, 429–431. [CrossRef] [PubMed]
    • (1991) Nature , vol.350 , pp. 429-431
    • Bressac, B.1    Kew, M.2    Wands, J.3    Ozturk, M.4
  • 12
    • 0029916475 scopus 로고    scopus 로고
    • Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1
    • Yan, R.Q.; Su, J.J.; Huang, D.R.; Gan, Y.C.; Yang, C.; Huang, G.H. Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1. J. Cancer Res. Clin. Oncol. 1996, 122, 289–295. [CrossRef] [PubMed]
    • (1996) J. Cancer Res. Clin. Oncol. , vol.122 , pp. 289-295
    • Yan, R.Q.1    Su, J.J.2    Huang, D.R.3    Gan, Y.C.4    Yang, C.5    Huang, G.H.6
  • 13
    • 84944906098 scopus 로고    scopus 로고
    • Functional and genetic deconstruction of the cellular origin in liver cancer
    • Marquardt, J.U.; Andersen, J.B.; Thorgeirsson, S.S. Functional and genetic deconstruction of the cellular origin in liver cancer. Nat. Rev. Cancer 2015, 15, 653–667. [CrossRef] [PubMed]
    • (2015) Nat. Rev. Cancer , vol.15 , pp. 653-667
    • Marquardt, J.U.1    Andersen, J.B.2    Thorgeirsson, S.S.3
  • 15
    • 84929129284 scopus 로고    scopus 로고
    • Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
    • Schulze, K. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 2015, 47, 505–511. [CrossRef] [PubMed]
    • (2015) Nat. Genet , vol.47 , pp. 505-511
    • Schulze, K.1
  • 16
    • 84861625981 scopus 로고    scopus 로고
    • Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
    • Guichard, C.; Amaddeo, G.; Imbeaud, S.; Ladeiro, Y.; Pelletier, L.; Maad, I.B.; Calderaro, J.; Bioulac-Sage, P.; Letexier, M.; Degos, F.; et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat. Genet. 2012, 44, 694–698. [CrossRef] [PubMed]
    • (2012) Nat. Genet. , vol.44 , pp. 694-698
    • Guichard, C.1    Amaddeo, G.2    Imbeaud, S.3    Ladeiro, Y.4    Pelletier, L.5    Maad, I.B.6    Calderaro, J.7    Bioulac-Sage, P.8    Letexier, M.9    Degos, F.10
  • 19
    • 0034681457 scopus 로고    scopus 로고
    • Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery
    • Rudolph, K.L.; Chang, S.; Millard, M.; Schreiber-Agus, N.; DePinho, R.A. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 2000, 287, 1253–1258. [CrossRef] [PubMed]
    • (2000) Science , vol.287 , pp. 1253-1258
    • Rudolph, K.L.1    Chang, S.2    Millard, M.3    Schreiber-Agus, N.4    Depinho, R.A.5
  • 20
    • 34248177482 scopus 로고    scopus 로고
    • Telomerase activation in liver regeneration and hepatocarcinogenesis: Dr. Jekyll or Mr. Hyde?
    • Wege, H.; Brummendorf, T.H. Telomerase activation in liver regeneration and hepatocarcinogenesis: Dr. Jekyll or Mr. Hyde? Curr. Stem Cell Res. Ther. 2007, 2, 31–38. [CrossRef] [PubMed]
    • (2007) Curr. Stem Cell Res. Ther. , vol.2 , pp. 31-38
    • Wege, H.1    Brummendorf, T.H.2
  • 22
    • 0042440603 scopus 로고    scopus 로고
    • Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma
    • Farazi, P.A.; Glickman, J.; Jiang, S.; Yu, A.; Rudolph, K.L.; DePinho, R.A. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res. 2003, 63, 5021–5027. [PubMed]
    • (2003) Cancer Res , vol.63 , pp. 5021-5027
    • Farazi, P.A.1    Glickman, J.2    Jiang, S.3    Yu, A.4    Rudolph, K.L.5    Depinho, R.A.6
  • 23
    • 84911902519 scopus 로고    scopus 로고
    • Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis
    • Nault, J.C.; Calderaro, J.; Di Tommaso, L.; Balabaud, C.; Zafrani, E.S.; Bioulac-Sage, P.; Roncalli, M.; Zucman-Rossi, J. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology 2014, 60, 1983–1992. [CrossRef] [PubMed]
    • (2014) Hepatology , vol.60 , pp. 1983-1992
    • Nault, J.C.1    Calderaro, J.2    Di Tommaso, L.3    Balabaud, C.4    Zafrani, E.S.5    Bioulac-Sage, P.6    Roncalli, M.7    Zucman-Rossi, J.8
  • 24
    • 84901472677 scopus 로고    scopus 로고
    • Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification
    • Ahn, S.M.; Jang, S.J.; Shim, J.H.; Kim, D.; Hong, S.M.; Sung, C.O.; Baek, D.; Haq, F.; Ansari, A.A.; Lee, S.Y.; et al. Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification. Hepatology 2014, 60, 1972–1982. [CrossRef] [PubMed]
    • (2014) Hepatology , vol.60 , pp. 1972-1982
    • Ahn, S.M.1    Jang, S.J.2    Shim, J.H.3    Kim, D.4    Hong, S.M.5    Sung, C.O.6    Baek, D.7    Haq, F.8    Ansari, A.A.9    Lee, S.Y.10
  • 26
    • 0042968962 scopus 로고    scopus 로고
    • Molecular viral oncology of hepatocellular carcinoma
    • Block, T.M.; Mehta, A.S.; Fimmel, C.J.; Jordan, R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003, 22, 5093–5107. [CrossRef] [PubMed]
    • (2003) Oncogene , vol.22 , pp. 5093-5107
    • Block, T.M.1    Mehta, A.S.2    Fimmel, C.J.3    Jordan, R.4
  • 27
    • 0026335594 scopus 로고
    • Chromosome deletions associated with hepatitis B virus integration
    • Tokino, T.; Tamura, H.; Hori, N.; Matsubara, K. Chromosome deletions associated with hepatitis B virus integration. Virology 1991, 185, 879–882. [CrossRef]
    • (1991) Virology , vol.185 , pp. 879-882
    • Tokino, T.1    Tamura, H.2    Hori, N.3    Matsubara, K.4
  • 28
    • 22644435919 scopus 로고    scopus 로고
    • Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas
    • Murakami, Y.; Saigo, K.; Takashima, H.; Minami, M.; Okanoue, T.; Brechot, C.; Paterlini-Brechot, P. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 2005, 54, 1162–1168. [CrossRef] [PubMed]
    • (2005) Gut , vol.54 , pp. 1162-1168
    • Murakami, Y.1    Saigo, K.2    Takashima, H.3    Minami, M.4    Okanoue, T.5    Brechot, C.6    Paterlini-Brechot, P.7
  • 29
    • 0035860752 scopus 로고    scopus 로고
    • Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes
    • Tarn, C.; Lee, S.; Hu, Y.; Ashendel, C.; Andrisani, O.M. Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes. J. Biol. Chem. 2001, 276, 34671–34680. [CrossRef] [PubMed]
    • (2001) J. Biol. Chem. , vol.276 , pp. 34671-34680
    • Tarn, C.1    Lee, S.2    Hu, Y.3    Ashendel, C.4    Andrisani, O.M.5
  • 30
    • 0034785734 scopus 로고    scopus 로고
    • Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo
    • Nijhara, R.; Jana, S.S.; Goswami, S.K.; Rana, A.; Majumdar, S.S.; Kumar, V.; Sarkar, D.P. Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo. J. Virol. 2001, 75, 10348–10358. [CrossRef] [PubMed]
    • (2001) J. Virol. , vol.75 , pp. 10348-10358
    • Nijhara, R.1    Jana, S.S.2    Goswami, S.K.3    Rana, A.4    Majumdar, S.S.5    Kumar, V.6    Sarkar, D.P.7
  • 31
    • 0035943513 scopus 로고    scopus 로고
    • An internal segment (Residues 58–119) of the hepatitis B virus X protein is sufficient to activate MAP kinase pathways in mouse liver
    • Nijhara, R.; Jana, S.S.; Goswami, S.K.; Kumar, V.; Sarkar, D.P. An internal segment (residues 58–119) of the hepatitis B virus X protein is sufficient to activate MAP kinase pathways in mouse liver. FEBS Lett. 2001, 504, 59–64. [CrossRef]
    • (2001) FEBS Lett , vol.504 , pp. 59-64
    • Nijhara, R.1    Jana, S.S.2    Goswami, S.K.3    Kumar, V.4    Sarkar, D.P.5
  • 33
    • 0033058294 scopus 로고    scopus 로고
    • Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein
    • Yu, D.Y.; Moon, H.B.; Son, J.K.; Jeong, S.; Yu, S.L.; Yoon, H.; Han, Y.M.; Lee, C.S.; Park, J.S.; Lee, C.H.; et al. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J. Hepatol. 1999, 31, 123–132. [CrossRef]
    • (1999) J. Hepatol. , vol.31 , pp. 123-132
    • Yu, D.Y.1    Moon, H.B.2    Son, J.K.3    Jeong, S.4    Yu, S.L.5    Yoon, H.6    Han, Y.M.7    Lee, C.S.8    Park, J.S.9    Lee, C.H.10
  • 34
    • 0025907983 scopus 로고
    • HBx gene of hepatitis B virus induces liver cancer in transgenic mice
    • Kim, C.-M.; Koike, K.; Saito, I.; Miyamura, T.; Jay, G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991, 351, 317–320. [CrossRef] [PubMed]
    • (1991) Nature , vol.351 , pp. 317-320
    • Kim, C.-M.1    Koike, K.2    Saito, I.3    Miyamura, T.4    Jay, G.5
  • 35
    • 2342588229 scopus 로고    scopus 로고
    • Genomic analysis of the host response to hepatitis B virus infection
    • Wieland, S.; Thimme, R.; Purcell, R.H.; Chisari, F.V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 2004, 101, 6669–6674. [CrossRef] [PubMed]
    • (2004) Proc. Natl. Acad. Sci. USA , vol.101 , pp. 6669-6674
    • Wieland, S.1    Thimme, R.2    Purcell, R.H.3    Chisari, F.V.4
  • 36
    • 14944375587 scopus 로고    scopus 로고
    • Immunology of hepatitis B virus and hepatitis C virus infection
    • Rehermann, B.; Nascimbeni, M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005, 5, 215–229. [CrossRef] [PubMed]
    • (2005) Nat. Rev. Immunol. , vol.5 , pp. 215-229
    • Rehermann, B.1    Nascimbeni, M.2
  • 37
    • 33747830764 scopus 로고    scopus 로고
    • Hepatocellular carcinoma pathogenesis: From genes to environment
    • Farazi, P.A.; DePinho, R.A. Hepatocellular carcinoma pathogenesis: From genes to environment. Nat. Rev. Immunol. 2006, 6, 674–687. [CrossRef] [PubMed]
    • (2006) Nat. Rev. Immunol. , vol.6 , pp. 674-687
    • Farazi, P.A.1    Depinho, R.A.2
  • 38
    • 23944476834 scopus 로고    scopus 로고
    • Unravelling hepatitis C virus replication from genome to function
    • Lindenbach, B.D.; Rice, C.M. Unravelling hepatitis C virus replication from genome to function. Nature 2005, 436, 933–938. [CrossRef] [PubMed]
    • (2005) Nature , vol.436 , pp. 933-938
    • Lindenbach, B.D.1    Rice, C.M.2
  • 41
    • 84954417122 scopus 로고    scopus 로고
    • Targeting Wnt/beta-catenin pathway in hepatocellular carcinoma treatment
    • Vilchez, V.; Turcios, L.; Marti, F.; Gedaly, R. Targeting Wnt/beta-catenin pathway in hepatocellular carcinoma treatment. World J. Gastroenterol. 2016, 22, 823–832. [CrossRef] [PubMed]
    • (2016) World J. Gastroenterol. , vol.22 , pp. 823-832
    • Vilchez, V.1    Turcios, L.2    Marti, F.3    Gedaly, R.4
  • 42
    • 1642535593 scopus 로고    scopus 로고
    • Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations
    • Harada, N.; Oshima, H.; Katoh, M.; Tamai, Y.; Oshima, M.; Taketo, M.M. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. Cancer Res. 2004, 64, 48–54. [CrossRef] [PubMed]
    • (2004) Cancer Res , vol.64 , pp. 48-54
    • Harada, N.1    Oshima, H.2    Katoh, M.3    Tamai, Y.4    Oshima, M.5    Taketo, M.M.6
  • 43
    • 84861986053 scopus 로고    scopus 로고
    • Wnt/beta-catenin signaling and disease
    • Clevers, H.; Nusse, R. Wnt/beta-catenin signaling and disease. Cell 2012, 149, 1192–1205. [CrossRef] [PubMed]
    • (2012) Cell , vol.149 , pp. 1192-1205
    • Clevers, H.1    Nusse, R.2
  • 44
    • 33645457576 scopus 로고    scopus 로고
    • Constitutive activation of NF-kappaB in human hepatocellular carcinoma: Evidence of a cytoprotective role
    • Qiao, L.; Zhang, H.; Yu, J.; Francisco, R.; Dent, P.; Ebert, M.P.; Rocken, C.; Farrell, G. Constitutive activation of NF-kappaB in human hepatocellular carcinoma: Evidence of a cytoprotective role. Hum. Gene Ther. 2006, 17, 280–290. [CrossRef] [PubMed]
    • (2006) Hum. Gene Ther. , vol.17 , pp. 280-290
    • Qiao, L.1    Zhang, H.2    Yu, J.3    Francisco, R.4    Dent, P.5    Ebert, M.P.6    Rocken, C.7    Farrell, G.8
  • 45
    • 70349308534 scopus 로고    scopus 로고
    • Mechanisms of liver disease: Cross-talk between the NF-kappaB and JNK pathways
    • Papa, S.; Bubici, C.; Zazzeroni, F.; Franzoso, G. Mechanisms of liver disease: Cross-talk between the NF-kappaB and JNK pathways. Biol. Chem. 2009, 390, 965–976. [CrossRef] [PubMed]
    • (2009) Biol. Chem. , vol.390 , pp. 965-976
    • Papa, S.1    Bubici, C.2    Zazzeroni, F.3    Franzoso, G.4
  • 46
    • 36549036709 scopus 로고    scopus 로고
    • A cell cycle regulatory network controlling NF-kappaB subunit activity and function
    • Barre, B.; Perkins, N.D. A cell cycle regulatory network controlling NF-kappaB subunit activity and function. EMBO J. 2007, 26, 4841–4855. [CrossRef] [PubMed]
    • (2007) EMBO J , vol.26 , pp. 4841-4855
    • Barre, B.1    Perkins, N.D.2
  • 47
    • 80051677812 scopus 로고    scopus 로고
    • P53-dependent regulation of mitochondrial energy production by the RelA subunit of NF-kappaB
    • Johnson, R.F.; Witzel, I.I.; Perkins, N.D. p53-dependent regulation of mitochondrial energy production by the RelA subunit of NF-kappaB. Cancer Res. 2011, 71, 5588–5597. [CrossRef] [PubMed]
    • (2011) Cancer Res , vol.71 , pp. 5588-5597
    • Johnson, R.F.1    Witzel, I.I.2    Perkins, N.D.3
  • 50
    • 85027460324 scopus 로고    scopus 로고
    • Molecular machineries of pH dysregulation in tumor microenvironment: Potential targets for cancer therapy
    • Asgharzadeh, M.R.; Barar, J.; Pourseif, M.M.; Eskandani, M.; Jafari Niya, M.; Mashayekhi, M.R.; Omidi, Y. Molecular machineries of pH dysregulation in tumor microenvironment: Potential targets for cancer therapy. Bioimpacts 2017, 7, 115–133. [CrossRef] [PubMed]
    • (2017) Bioimpacts , vol.7 , pp. 115-133
    • Asgharzadeh, M.R.1    Barar, J.2    Pourseif, M.M.3    Eskandani, M.4    Jafari Niya, M.5    Mashayekhi, M.R.6    Omidi, Y.7
  • 51
    • 84870376274 scopus 로고    scopus 로고
    • N-acetylcysteine improves antitumoural response of Interferon alpha by NF-kB downregulation in liver cancer cells
    • Kretzmann, N.A.; Chiela, E.; Matte, U.; Marroni, N.; Marroni, C.A. N-acetylcysteine improves antitumoural response of Interferon alpha by NF-kB downregulation in liver cancer cells. Comp. Hepatol. 2012, 11, 4. [CrossRef] [PubMed]
    • (2012) Comp. Hepatol. , vol.11 , pp. 4
    • Kretzmann, N.A.1    Chiela, E.2    Matte, U.3    Marroni, N.4    Marroni, C.A.5
  • 52
    • 79951829343 scopus 로고    scopus 로고
    • Hypoxia and inflammation
    • Eltzschig, H.K.; Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med. 2011, 364, 656–665. [CrossRef] [PubMed]
    • (2011) N. Engl. J. Med. , vol.364 , pp. 656-665
    • Eltzschig, H.K.1    Carmeliet, P.2
  • 53
    • 70249099576 scopus 로고    scopus 로고
    • Interdependence of hypoxic and innate immune responses
    • Nizet, V.; Johnson, R.S. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 2009, 9, 609–617. [CrossRef] [PubMed]
    • (2009) Nat. Rev. Immunol. , vol.9 , pp. 609-617
    • Nizet, V.1    Johnson, R.S.2
  • 54
    • 85041503582 scopus 로고    scopus 로고
    • Tumor hypoxia as an enhancer of inflammation-mediated metastasis: Emerging therapeutic strategies
    • DiGiacomo, J.W.; Gilkes, D.M. Tumor hypoxia as an enhancer of inflammation-mediated metastasis: Emerging therapeutic strategies. Target. Oncol. 2018, 13, 157–173. [CrossRef] [PubMed]
    • (2018) Target. Oncol. , vol.13 , pp. 157-173
    • Digiacomo, J.W.1    Gilkes, D.M.2
  • 57
    • 84955270341 scopus 로고    scopus 로고
    • An imbalance in TAZ and YAP expression in hepatocellular carcinoma confers cancer stem cell-like behaviors contributing to disease progression
    • Hayashi, H.; Higashi, T.; Yokoyama, N.; Kaida, T.; Sakamoto, K.; Fukushima, Y.; Ishimoto, T.; Kuroki, H.; Nitta, H.; Hashimoto, D.; et al. An imbalance in TAZ and YAP expression in hepatocellular carcinoma confers cancer stem cell-like behaviors contributing to disease progression. Cancer Res. 2015, 75, 4985–4997. [CrossRef] [PubMed]
    • (2015) Cancer Res , vol.75 , pp. 4985-4997
    • Hayashi, H.1    Higashi, T.2    Yokoyama, N.3    Kaida, T.4    Sakamoto, K.5    Fukushima, Y.6    Ishimoto, T.7    Kuroki, H.8    Nitta, H.9    Hashimoto, D.10
  • 58
    • 84980018556 scopus 로고    scopus 로고
    • Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma
    • Wu, H.; Liu, Y.; Jiang, X.W.; Li, W.F.; Guo, G.; Gong, J.P.; Ding, X. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma. Tumor Biol. 2016, 37, 13499–13508. [CrossRef] [PubMed]
    • (2016) Tumor Biol , vol.37 , pp. 13499-13508
    • Wu, H.1    Liu, Y.2    Jiang, X.W.3    Li, W.F.4    Guo, G.5    Gong, J.P.6    Ding, X.7
  • 60
    • 84884291548 scopus 로고    scopus 로고
    • Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2
    • Yin, F.; Yu, J.; Zheng, Y.; Chen, Q.; Zhang, N.; Pan, D. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 2013, 154, 1342–1355. [CrossRef] [PubMed]
    • (2013) Cell , vol.154 , pp. 1342-1355
    • Yin, F.1    Yu, J.2    Zheng, Y.3    Chen, Q.4    Zhang, N.5    Pan, D.6
  • 61
    • 0034092011 scopus 로고    scopus 로고
    • Tumor angiogenesis: Past, present and the near future
    • Kerbel, R.S. Tumor angiogenesis: Past, present and the near future. Carcinogenesis 2000, 21, 505–515. [CrossRef] [PubMed]
    • (2000) Carcinogenesis , vol.21 , pp. 505-515
    • Kerbel, R.S.1
  • 63
    • 84991795131 scopus 로고    scopus 로고
    • Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
    • 360ra135. [CrossRef] [PubMed
    • Rahbari, N.N.; Kedrin, D.; Incio, J.; Liu, H.; Ho, W.W.; Nia, H.T.; Edrich, C.M.; Jung, K.; Daubriac, J.; Chen, I.; et al. Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases. Sci. Transl. Med. 2016, 8, 360ra135. [CrossRef] [PubMed]
    • (2016) Sci. Transl. Med. , vol.8
    • Rahbari, N.N.1    Kedrin, D.2    Incio, J.3    Liu, H.4    Ho, W.W.5    Nia, H.T.6    Edrich, C.M.7    Jung, K.8    Daubriac, J.9    Chen, I.10
  • 65
    • 84862650711 scopus 로고    scopus 로고
    • Low VEGF expression in conceptus material and maternal serum AFP and beta-hCG levels as indicators of defective angiogenesis in first-trimester miscarriages
    • Kutluer, G.; Cicek, N.M.; Moraloglu, O.; Ertargin, P.; Sarikaya, E.; Artar, I.; Erdem, O. Low VEGF expression in conceptus material and maternal serum AFP and beta-hCG levels as indicators of defective angiogenesis in first-trimester miscarriages. J. Turk. Ger. Gynecol. Assoc. 2012, 13, 111–117. [PubMed]
    • (2012) J. Turk. Ger. Gynecol. Assoc. , vol.13 , pp. 111-117
    • Kutluer, G.1    Cicek, N.M.2    Moraloglu, O.3    Ertargin, P.4    Sarikaya, E.5    Artar, I.6    Erdem, O.7
  • 66
    • 84966480845 scopus 로고    scopus 로고
    • Thrombosis recanalization by paeoniflorin through the upregulation of urokinasetype plasminogen activator via the MAPK signaling pathway
    • Ye, S.; Mao, B.; Yang, L.; Fu, W.; Hou, J. Thrombosis recanalization by paeoniflorin through the upregulation of urokinasetype plasminogen activator via the MAPK signaling pathway. Mol. Med. Rep. 2016, 13, 4593–4598. [CrossRef] [PubMed]
    • (2016) Mol. Med. Rep. , vol.13 , pp. 4593-4598
    • Ye, S.1    Mao, B.2    Yang, L.3    Fu, W.4    Hou, J.5
  • 67
    • 85041660436 scopus 로고    scopus 로고
    • Urokinase type plasminogen activator and the molecular mechanisms of its regulation in cancer
    • Santibanez, J.F. Urokinase type plasminogen activator and the molecular mechanisms of its regulation in cancer. Protein Pept. Lett. 2017, 24, 936–946. [CrossRef] [PubMed]
    • (2017) Protein Pept. Lett , vol.24 , pp. 936-946
    • Santibanez, J.F.1
  • 69
    • 84984918509 scopus 로고    scopus 로고
    • UPA/uPAR and SERPINE1 in head and neck cancer: Role in tumor resistance, metastasis, prognosis and therapy
    • Pavon, M.A.; Arroyo-Solera, I.; Cespedes, M.V.; Casanova, I.; Leon, X.; Mangues, R. uPA/uPAR and SERPINE1 in head and neck cancer: Role in tumor resistance, metastasis, prognosis and therapy. Oncotarget 2016, 7, 57351–57366. [CrossRef] [PubMed]
    • (2016) Oncotarget , vol.7 , pp. 57351-57366
    • Pavon, M.A.1    Arroyo-Solera, I.2    Cespedes, M.V.3    Casanova, I.4    Leon, X.5    Mangues, R.6
  • 71
    • 84859203369 scopus 로고    scopus 로고
    • Expression of urokinase-type plasminogen activator (UPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance
    • Andres, S.A.; Edwards, A.B.; Wittliff, J.L. Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance. J. Clin. Lab. Anal. 2012, 26, 93–103. [CrossRef] [PubMed]
    • (2012) J. Clin. Lab. Anal. , vol.26 , pp. 93-103
    • Andres, S.A.1    Edwards, A.B.2    Wittliff, J.L.3
  • 73
    • 84896975948 scopus 로고    scopus 로고
    • Role of uPA/uPAR in the modulation of angiogenesis
    • PubMed
    • Montuori, N.; Ragno, P. Role of uPA/uPAR in the modulation of angiogenesis. Chem. Immunol. Allergy 2014, 99, 105–122. [PubMed]
    • (2014) Chem. Immunol. Allergy , vol.99 , pp. 105-122
    • Montuori, N.1    Ragno, P.2
  • 74
    • 79952674668 scopus 로고    scopus 로고
    • Targeting integrins in hepatocellular carcinoma
    • Wu, Y.; Qiao, X.; Qiao, S.; Yu, L. Targeting integrins in hepatocellular carcinoma. Expert Opin. Ther. Targets 2011, 15, 421–437. [CrossRef] [PubMed]
    • (2011) Expert Opin. Ther. Targets , vol.15 , pp. 421-437
    • Wu, Y.1    Qiao, X.2    Qiao, S.3    Yu, L.4
  • 76
    • 84918586280 scopus 로고    scopus 로고
    • Integrins αvβ6, α6β4 and α3β1 are down-regulated in cholangiolocellular carcinoma but not cholangiocarcinoma
    • Soejima, Y.; Inoue, M.; Takahashi, Y.; Uozaki, H.; Sawabe, M.; Fukusato, T. Integrins αvβ6, α6β4 and α3β1 are down-regulated in cholangiolocellular carcinoma but not cholangiocarcinoma. Hepatol. Res. 2014, 44, 320–334. [CrossRef] [PubMed]
    • (2014) Hepatol. Res. , vol.44 , pp. 320-334
    • Soejima, Y.1    Inoue, M.2    Takahashi, Y.3    Uozaki, H.4    Sawabe, M.5    Fukusato, T.6
  • 77
  • 78
    • 85044821162 scopus 로고    scopus 로고
    • Beta1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway
    • Tian, T.; Li, C.L.; Fu, X.; Wang, S.H.; Lu, J.; Guo, H.; Yao, Y.; Nan, K.J.; Yang, Y.J. beta1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway. J. Int. Med. Res. 2018, 46, 1311–1325. [CrossRef] [PubMed]
    • (2018) J. Int. Med. Res , vol.46 , pp. 1311-1325
    • Tian, T.1    Li, C.L.2    Fu, X.3    Wang, S.H.4    Lu, J.5    Guo, H.6    Yao, Y.7    Nan, K.J.8    Yang, Y.J.9
  • 79
    • 85030254883 scopus 로고    scopus 로고
    • Cross-talk mechanism between endothelial cells and hepatocellular carcinoma cells via growth factors and integrin pathway promotes tumor angiogenesis and cell migration
    • Feng, T.; Yu, H.; Xia, Q.; Ma, Y.; Yin, H.; Shen, Y.; Liu, X. Cross-talk mechanism between endothelial cells and hepatocellular carcinoma cells via growth factors and integrin pathway promotes tumor angiogenesis and cell migration. Oncotarget 2017, 8, 69577–69593. [CrossRef] [PubMed]
    • (2017) Oncotarget , vol.8 , pp. 69577-69593
    • Feng, T.1    Yu, H.2    Xia, Q.3    Ma, Y.4    Yin, H.5    Shen, Y.6    Liu, X.7
  • 80
    • 85049476805 scopus 로고    scopus 로고
    • Farnesoid X receptor activation enhances transforming growth factor beta-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells
    • Kainuma, M.; Takada, I.; Makishima, M.; Sano, K. Farnesoid X receptor activation enhances transforming growth factor beta-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells. Int. J. Mol. Sci. 2018, 19, 1898. [CrossRef] [PubMed]
    • (2018) Int. J. Mol. Sci. , vol.19 , pp. 1898
    • Kainuma, M.1    Takada, I.2    Makishima, M.3    Sano, K.4
  • 81
    • 33645821043 scopus 로고    scopus 로고
    • Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration
    • Huang, W.; Ma, K.; Zhang, J.; Qatanani, M.; Cuvillier, J.; Liu, J.; Dong, B.; Huang, X.; Moore, D.D. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006, 312, 233–236. [CrossRef] [PubMed]
    • (2006) Science , vol.312 , pp. 233-236
    • Huang, W.1    Ma, K.2    Zhang, J.3    Qatanani, M.4    Cuvillier, J.5    Liu, J.6    Dong, B.7    Huang, X.8    Moore, D.D.9
  • 83
    • 84867305638 scopus 로고    scopus 로고
    • FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model
    • Deuschle, U.; Schuler, J.; Schulz, A.; Schluter, T.; Kinzel, O.; Abel, U.; Kremoser, C. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model. PLoS ONE 2012, 7, e43044. [CrossRef] [PubMed]
    • (2012) Plos ONE , vol.7
    • Deuschle, U.1    Schuler, J.2    Schulz, A.3    Schluter, T.4    Kinzel, O.5    Abel, U.6    Kremoser, C.7
  • 84
    • 33847044019 scopus 로고    scopus 로고
    • Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor
    • Yang, F.; Huang, X.; Yi, T.; Yen, Y.; Moore, D.D.; Huang, W. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Cancer Res. 2007, 67, 863–867. [CrossRef] [PubMed]
    • (2007) Cancer Res , vol.67 , pp. 863-867
    • Yang, F.1    Huang, X.2    Yi, T.3    Yen, Y.4    Moore, D.D.5    Huang, W.6
  • 86
    • 34447098081 scopus 로고    scopus 로고
    • Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
    • Kim, I.; Morimura, K.; Shah, Y.; Yang, Q.; Ward, J.M.; Gonzalez, F.J. Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis 2007, 28, 940–946. [CrossRef] [PubMed]
    • (2007) Carcinogenesis , vol.28 , pp. 940-946
    • Kim, I.1    Morimura, K.2    Shah, Y.3    Yang, Q.4    Ward, J.M.5    Gonzalez, F.J.6
  • 87
    • 85010671909 scopus 로고    scopus 로고
    • Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis
    • Niu, Y.; Xu, M.; Slagle, B.L.; Huang, H.; Li, S.; Guo, G.L.; Shi, G.; Qin, W.; Xie, W. Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis. Hepatology 2017, 65, 893–906. [CrossRef] [PubMed]
    • (2017) Hepatology , vol.65 , pp. 893-906
    • Niu, Y.1    Xu, M.2    Slagle, B.L.3    Huang, H.4    Li, S.5    Guo, G.L.6    Shi, G.7    Qin, W.8    Xie, W.9
  • 89
    • 48249153424 scopus 로고    scopus 로고
    • Apoptosis and hepatic necroinflammation
    • Gores, G.J. Apoptosis and hepatic necroinflammation. Gastroenterol. Hepatol. 2008, 4, 394–395.
    • (2008) Gastroenterol. Hepatol. , vol.4 , pp. 394-395
    • Gores, G.J.1
  • 91
    • 84922394053 scopus 로고    scopus 로고
    • Regulated cell death and inflammation: An auto-amplification loop causes organ failure
    • Linkermann, A.; Stockwell, B.R.; Krautwald, S.; Anders, H.J. Regulated cell death and inflammation: An auto-amplification loop causes organ failure. Nat. Rev. Immunol. 2014, 14, 759–767. [CrossRef] [PubMed]
    • (2014) Nat. Rev. Immunol. , vol.14 , pp. 759-767
    • Linkermann, A.1    Stockwell, B.R.2    Krautwald, S.3    Anders, H.J.4
  • 92
    • 84936891896 scopus 로고    scopus 로고
    • Inflammasomes: Mechanism of action, role in disease, and therapeutics
    • Guo, H.; Callaway, J.B.; Ting, J.P.Y. Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nat. Med. 2015, 21, 677. [CrossRef] [PubMed]
    • (2015) Nat. Med. , vol.21 , pp. 677
    • Guo, H.1    Callaway, J.B.2    Ting, J.P.Y.3
  • 93
    • 74549206702 scopus 로고    scopus 로고
    • How the noninflammasome NLRs function in the innate immune system
    • Ting, J.P.; Duncan, J.A.; Lei, Y. How the noninflammasome NLRs function in the innate immune system. Science 2010, 327, 286–290. [CrossRef] [PubMed]
    • (2010) Science , vol.327 , pp. 286-290
    • Ting, J.P.1    Duncan, J.A.2    Lei, Y.3
  • 94
    • 84858761335 scopus 로고    scopus 로고
    • Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1
    • Gross, O.; Yazdi, A.S.; Thomas, C.J.; Masin, M.; Heinz, L.X.; Guarda, G.; Quadroni, M.; Drexler, S.K.; Tschopp, J. Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1. Immunity 2012, 36, 388–400. [CrossRef] [PubMed]
    • (2012) Immunity , vol.36 , pp. 388-400
    • Gross, O.1    Yazdi, A.S.2    Thomas, C.J.3    Masin, M.4    Heinz, L.X.5    Guarda, G.6    Quadroni, M.7    Drexler, S.K.8    Tschopp, J.9
  • 96
    • 69949105157 scopus 로고    scopus 로고
    • The NLRP3 inflammasome: A sensor of immune danger signals
    • Cassel, S.L.; Joly, S.; Sutterwala, F.S. The NLRP3 inflammasome: A sensor of immune danger signals. Semin. Immunol. 2009, 21, 194–198. [CrossRef] [PubMed]
    • (2009) Semin. Immunol. , vol.21 , pp. 194-198
    • Cassel, S.L.1    Joly, S.2    Sutterwala, F.S.3
  • 97
    • 84930788521 scopus 로고    scopus 로고
    • Beyond canonical inflammasomes: Emerging pathways in IL-1-mediated autoinflammatory disease
    • Lukens, J.R.; Kanneganti, T.D. Beyond canonical inflammasomes: Emerging pathways in IL-1-mediated autoinflammatory disease. Semin. Immunopathol. 2014, 36, 595–609. [CrossRef] [PubMed]
    • (2014) Semin. Immunopathol. , vol.36 , pp. 595-609
    • Lukens, J.R.1    Kanneganti, T.D.2
  • 98
    • 84906247578 scopus 로고    scopus 로고
    • Inflammasome activation has an important role in the development of spontaneous colitis
    • Zhang, J.; Fu, S.; Sun, S.; Li, Z.; Guo, B. Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol. 2014, 7, 1139–1150. [CrossRef] [PubMed]
    • (2014) Mucosal Immunol , vol.7 , pp. 1139-1150
    • Zhang, J.1    Fu, S.2    Sun, S.3    Li, Z.4    Guo, B.5
  • 99
    • 84901310586 scopus 로고    scopus 로고
    • Mechanisms and functions of inflammasomes
    • Lamkanfi, M.; Dixit, V.M. Mechanisms and functions of inflammasomes. Cell 2014, 157, 1013–1022. [CrossRef] [PubMed]
    • (2014) Cell , vol.157 , pp. 1013-1022
    • Lamkanfi, M.1    Dixit, V.M.2
  • 100
    • 84858643750 scopus 로고    scopus 로고
    • Inflammasomes in carcinogenesis and anticancer immune responses
    • Zitvogel, L.; Kepp, O.; Galluzzi, L.; Kroemer, G. Inflammasomes in carcinogenesis and anticancer immune responses. Nat. Immunol. 2012, 13, 343–351. [CrossRef] [PubMed]
    • (2012) Nat. Immunol. , vol.13 , pp. 343-351
    • Zitvogel, L.1    Kepp, O.2    Galluzzi, L.3    Kroemer, G.4
  • 101
    • 79956300649 scopus 로고    scopus 로고
    • Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
    • Kawai, T.; Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34, 637–650. [CrossRef] [PubMed]
    • (2011) Immunity , vol.34 , pp. 637-650
    • Kawai, T.1    Akira, S.2
  • 102
    • 84918564833 scopus 로고    scopus 로고
    • Toll-like receptor signaling pathways
    • Kawasaki, T.; Kawai, T. Toll-like receptor signaling pathways. Front. Immunol. 2014, 5, 461. [CrossRef] [PubMed]
    • (2014) Front. Immunol. , vol.5 , pp. 461
    • Kawasaki, T.1    Kawai, T.2
  • 103
    • 0036671894 scopus 로고    scopus 로고
    • The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta
    • Martinon, F.; Burns, K.; Tschopp, J. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10, 417–426. [CrossRef]
    • (2002) Mol. Cell , vol.10 , pp. 417-426
    • Martinon, F.1    Burns, K.2    Tschopp, J.3
  • 104
    • 66749174867 scopus 로고    scopus 로고
    • The inflammasomes: Guardians of the body
    • Martinon, F.; Mayor, A.; Tschopp, J. The inflammasomes: Guardians of the body. Ann. Rev. Immunol. 2009, 27, 229–265. [CrossRef] [PubMed]
    • (2009) Ann. Rev. Immunol. , vol.27 , pp. 229-265
    • Martinon, F.1    Mayor, A.2    Tschopp, J.3
  • 105
    • 39149116674 scopus 로고    scopus 로고
    • NLR, the nucleotide-binding domain leucine-rich repeat containing gene family
    • Ye, Z.; Ting, J.P. NLR, the nucleotide-binding domain leucine-rich repeat containing gene family. Curr. Opin. Immunol. 2008, 20, 3–9. [CrossRef] [PubMed]
    • (2008) Curr. Opin. Immunol. , vol.20 , pp. 3-9
    • Ye, Z.1    Ting, J.P.2
  • 107
    • 67049158193 scopus 로고    scopus 로고
    • The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
    • Cayrol, C.; Girard, J.P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 2009, 106, 9021–9026. [CrossRef] [PubMed]
    • (2009) Proc. Natl. Acad. Sci. USA , vol.106 , pp. 9021-9026
    • Cayrol, C.1    Girard, J.P.2
  • 108
    • 77950362382 scopus 로고    scopus 로고
    • The inflammasomes
    • Schroder, K.; Tschopp, J. The inflammasomes. Cell 2010, 140, 821–832. [CrossRef] [PubMed]
    • (2010) Cell , vol.140 , pp. 821-832
    • Schroder, K.1    Tschopp, J.2
  • 109
    • 79959573042 scopus 로고    scopus 로고
    • Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells
    • Csak, T.; Ganz, M.; Pespisa, J.; Kodys, K.; Dolganiuc, A.; Szabo, G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011, 54, 133–144. [CrossRef] [PubMed]
    • (2011) Hepatology , vol.54 , pp. 133-144
    • Csak, T.1    Ganz, M.2    Pespisa, J.3    Kodys, K.4    Dolganiuc, A.5    Szabo, G.6
  • 110
    • 84870062861 scopus 로고    scopus 로고
    • Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease
    • Boaru, S.G.; Borkham-Kamphorst, E.; Tihaa, L.; Haas, U.; Weiskirchen, R. Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease. J. Inflamm. 2012, 9, 49. [CrossRef] [PubMed]
    • (2012) J. Inflamm. , vol.9 , pp. 49
    • Boaru, S.G.1    Borkham-Kamphorst, E.2    Tihaa, L.3    Haas, U.4    Weiskirchen, R.5
  • 111
    • 78650859531 scopus 로고    scopus 로고
    • NF-κB and STAT3–key players in liver inflammation and cancer
    • He, G.; Karin, M. NF-κB and STAT3–key players in liver inflammation and cancer. Cell Res. 2011, 21, 159–168. [CrossRef] [PubMed]
    • (2011) Cell Res , vol.21 , pp. 159-168
    • He, G.1    Karin, M.2
  • 112
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: The next generation
    • Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646–674. [CrossRef] [PubMed]
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 113
    • 79751492851 scopus 로고    scopus 로고
    • NF-κB in the liver—Linking injury, fibrosis and hepatocellular carcinoma
    • Luedde, T.; Schwabe, R.F. NF-κB in the liver—Linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 2011, 8, 108–118. [CrossRef] [PubMed]
    • (2011) Nat. Rev. Gastroenterol. Hepatol. , vol.8 , pp. 108-118
    • Luedde, T.1    Schwabe, R.F.2
  • 114
    • 0034046605 scopus 로고    scopus 로고
    • STAT family of transcription factors in cytokine-mediated biological responses
    • Takeda, K.; Akira, S. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 2000, 11, 199–207. [CrossRef]
    • (2000) Cytokine Growth Factor Rev , vol.11 , pp. 199-207
    • Takeda, K.1    Akira, S.2
  • 115
    • 0034658541 scopus 로고    scopus 로고
    • Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors
    • Hirano, T.; Ishihara, K.; Hibi, M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000, 19, 2548–2556. [CrossRef] [PubMed]
    • (2000) Oncogene , vol.19 , pp. 2548-2556
    • Hirano, T.1    Ishihara, K.2    Hibi, M.3
  • 116
    • 85026219642 scopus 로고    scopus 로고
    • New insights into the role of autophagy in tumor immune microenvironment
    • Li, C.J.; Liao, W.T.; Wu, M.Y.; Chu, P.Y. New insights into the role of autophagy in tumor immune microenvironment. Int. J. Mol. Sci. 2017, 18, 1566. [CrossRef] [PubMed]
    • (2017) Int. J. Mol. Sci. , vol.18 , pp. 1566
    • Li, C.J.1    Liao, W.T.2    Wu, M.Y.3    Chu, P.Y.4
  • 117
    • 0036379718 scopus 로고    scopus 로고
    • Downregulation of the proteasome subunits, transporter, and antigen presentation in hepatocellular carcinoma, and their restoration by interferon-gamma
    • Matsui, M.; Machida, S.; Itani-Yohda, T.; Akatsuka, T. Downregulation of the proteasome subunits, transporter, and antigen presentation in hepatocellular carcinoma, and their restoration by interferon-gamma. J. Gastroenterol. Hepatol. 2002, 17, 897–907. [CrossRef] [PubMed]
    • (2002) J. Gastroenterol. Hepatol. , vol.17 , pp. 897-907
    • Matsui, M.1    Machida, S.2    Itani-Yohda, T.3    Akatsuka, T.4
  • 118
    • 16844378685 scopus 로고    scopus 로고
    • Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma
    • Ormandy, L.A.; Hillemann, T.; Wedemeyer, H.; Manns, M.P.; Greten, T.F.; Korangy, F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 2005, 65, 2457–2464. [CrossRef] [PubMed]
    • (2005) Cancer Res , vol.65 , pp. 2457-2464
    • Ormandy, L.A.1    Hillemann, T.2    Wedemeyer, H.3    Manns, M.P.4    Greten, T.F.5    Korangy, F.6
  • 121
    • 46049098560 scopus 로고    scopus 로고
    • A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells
    • Hoechst, B.; Ormandy, L.A.; Ballmaier, M.; Lehner, F.; Kruger, C.; Manns, M.P.; Greten, T.F.; Korangy, F. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008, 135, 234–243. [CrossRef] [PubMed]
    • (2008) Gastroenterology , vol.135 , pp. 234-243
    • Hoechst, B.1    Ormandy, L.A.2    Ballmaier, M.3    Lehner, F.4    Kruger, C.5    Manns, M.P.6    Greten, T.F.7    Korangy, F.8
  • 122
    • 45749137283 scopus 로고    scopus 로고
    • High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma
    • Zhu, X.D.; Zhang, J.B.; Zhuang, P.Y.; Zhu, H.G.; Zhang, W.; Xiong, Y.Q.; Wu, W.Z.; Wang, L.; Tang, Z.Y.; Sun, H.C. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2008, 26, 2707–2716. [CrossRef] [PubMed]
    • (2008) J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol , vol.26 , pp. 2707-2716
    • Zhu, X.D.1    Zhang, J.B.2    Zhuang, P.Y.3    Zhu, H.G.4    Zhang, W.5    Xiong, Y.Q.6    Wu, W.Z.7    Wang, L.8    Tang, Z.Y.9    Sun, H.C.10
  • 123
    • 84922980334 scopus 로고    scopus 로고
    • Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma
    • Yeung, O.W.; Lo, C.M.; Ling, C.C.; Qi, X.; Geng, W.; Li, C.X.; Ng, K.T.; Forbes, S.J.; Guan, X.Y.; Poon, R.T.; et al. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. J. Hepatol. 2015, 62, 607–616. [CrossRef] [PubMed]
    • (2015) J. Hepatol. , vol.62 , pp. 607-616
    • Yeung, O.W.1    Lo, C.M.2    Ling, C.C.3    Qi, X.4    Geng, W.5    Li, C.X.6    Ng, K.T.7    Forbes, S.J.8    Guan, X.Y.9    Poon, R.T.10
  • 124
    • 59049106749 scopus 로고    scopus 로고
    • High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection
    • Ding, T.; Xu, J.; Wang, F.; Shi, M.; Zhang, Y.; Li, S.P.; Zheng, L. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum. Pathol. 2009, 40, 381–389. [CrossRef] [PubMed]
    • (2009) Hum. Pathol. , vol.40 , pp. 381-389
    • Ding, T.1    Xu, J.2    Wang, F.3    Shi, M.4    Zhang, Y.5    Li, S.P.6    Zheng, L.7
  • 125
    • 76949094210 scopus 로고    scopus 로고
    • Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease
    • Behboudi, S.; Alisa, A.; Boswell, S.; Anastassiou, J.; Pathan, A.A.; Williams, R. Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease. Br. J. Cancer 2010, 102, 748–753. [CrossRef] [PubMed]
    • (2010) Br. J. Cancer , vol.102 , pp. 748-753
    • Behboudi, S.1    Alisa, A.2    Boswell, S.3    Anastassiou, J.4    Pathan, A.A.5    Williams, R.6
  • 126
    • 85030100079 scopus 로고    scopus 로고
    • New insights into the role of inflammation in the pathogenesis of atherosclerosis
    • Wu, M.-Y.; Li, C.-J.; Hou, M.-F.; Chu, P.-Y. New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int. J. Mol. Sci. 2017, 18, 2034. [CrossRef] [PubMed]
    • (2017) Int. J. Mol. Sci. , vol.18 , pp. 2034
    • Wu, M.-Y.1    Li, C.-J.2    Hou, M.-F.3    Chu, P.-Y.4
  • 127
    • 85116953324 scopus 로고    scopus 로고
    • Role of nonresolving inflammation in hepatocellular carcinoma development and progression
    • Yu, L.-X.; Ling, Y.; Wang, H.-Y. Role of nonresolving inflammation in hepatocellular carcinoma development and progression. NPJ Precis. Oncol. 2018, 2, 6. [CrossRef] [PubMed]
    • (2018) NPJ Precis. Oncol. , vol.2 , pp. 6
    • Yu, L.-X.1    Ling, Y.2    Wang, H.-Y.3
  • 128
    • 33747029250 scopus 로고    scopus 로고
    • Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
    • Budhu, A.; Forgues, M.; Ye, Q.H.; Jia, H.L.; He, P.; Zanetti, K.A.; Kammula, U.S.; Chen, Y.; Qin, L.X.; Tang, Z.Y.; et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006, 10, 99–111. [CrossRef] [PubMed]
    • (2006) Cancer Cell , vol.10 , pp. 99-111
    • Budhu, A.1    Forgues, M.2    Ye, Q.H.3    Jia, H.L.4    He, P.5    Zanetti, K.A.6    Kammula, U.S.7    Chen, Y.8    Qin, L.X.9    Tang, Z.Y.10
  • 130
    • 84864215495 scopus 로고    scopus 로고
    • In vitro angiogenesis assay for the study of cell-encapsulation therapy
    • Kim, C.; Chung, S.; Yuchun, L.; Kim, M.C.; Chan, J.K.; Asada, H.H.; Kamm, R.D. In vitro angiogenesis assay for the study of cell-encapsulation therapy. Lab Chip 2012, 12, 2942–2950. [CrossRef] [PubMed]
    • (2012) Lab Chip , vol.12 , pp. 2942-2950
    • Kim, C.1    Chung, S.2    Yuchun, L.3    Kim, M.C.4    Chan, J.K.5    Asada, H.H.6    Kamm, R.D.7
  • 131
    • 84942551966 scopus 로고    scopus 로고
    • Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma
    • Won, C.; Kim, B.H.; Yi, E.H.; Choi, K.J.; Kim, E.K.; Jeong, J.M.; Lee, J.H.; Jang, J.J.; Yoon, J.H.; Jeong, W.I.; et al. Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma. Hepatology 2015, 62, 1160–1173. [CrossRef] [PubMed]
    • (2015) Hepatology , vol.62 , pp. 1160-1173
    • Won, C.1    Kim, B.H.2    Yi, E.H.3    Choi, K.J.4    Kim, E.K.5    Jeong, J.M.6    Lee, J.H.7    Jang, J.J.8    Yoon, J.H.9    Jeong, W.I.10
  • 132
    • 84938745385 scopus 로고    scopus 로고
    • Programmed probiotics light up liver cancer in urine
    • Ray, K. Diagnosis: Programmed probiotics light up liver cancer in urine. Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 429. [CrossRef] [PubMed]
    • (2015) Nat. Rev. Gastroenterol. Hepatol. , vol.12 , pp. 429
    • Ray, K.D.1
  • 134
    • 84979090945 scopus 로고    scopus 로고
    • Nutrition status and small intestinal bacterial overgrowth in patients with virus-related cirrhosis
    • PubMed
    • Yao, J.; Chang, L.; Yuan, L.; Duan, Z. Nutrition status and small intestinal bacterial overgrowth in patients with virus-related cirrhosis. Asia Pac. J. Clin. Nutr. 2016, 25, 283–291. [PubMed]
    • (2016) Asia Pac. J. Clin. Nutr. , vol.25 , pp. 283-291
    • Yao, J.1    Chang, L.2    Yuan, L.3    Duan, Z.4
  • 135
    • 84959440187 scopus 로고    scopus 로고
    • TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells
    • Lin, A.; Wang, G.; Zhao, H.; Zhang, Y.; Han, Q.; Zhang, C.; Tian, Z.; Zhang, J. TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells. Oncoimmunology 2016, 5, e1074376. [CrossRef] [PubMed]
    • (2016) Oncoimmunology , vol.5
    • Lin, A.1    Wang, G.2    Zhao, H.3    Zhang, Y.4    Han, Q.5    Zhang, C.6    Tian, Z.7    Zhang, J.8
  • 136
    • 85046692457 scopus 로고    scopus 로고
    • Efficacy and Safety of neoadjuvant treatment with bevacizumab, liposomal doxorubicin, cyclophosphamide and paclitaxel combination in locally/regionally advanced, HER2-negative, Grade III at premenopausal status breast cancer: A Phase II Study
    • Tampaki, E.C.; Tampakis, A.; Alifieris, C.E.; Krikelis, D.; Pazaiti, A.; Kontos, M.; Trafalis, D.T. Efficacy and Safety of neoadjuvant treatment with bevacizumab, liposomal doxorubicin, cyclophosphamide and paclitaxel combination in locally/regionally advanced, HER2-negative, Grade III at premenopausal status breast cancer: A Phase II Study. Clin. Drug Investig. 2018. [CrossRef] [PubMed]
    • (2018) Clin. Drug Investig.
    • Tampaki, E.C.1    Tampakis, A.2    Alifieris, C.E.3    Krikelis, D.4    Pazaiti, A.5    Kontos, M.6    Trafalis, D.T.7
  • 138
    • 84948844664 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: A Phase II randomized controlled double-blind trial of transarterial chemoembolization in combination with biweekly intravenous administration of bevacizumab or a placebo
    • Pinter, M.; Ulbrich, G.; Sieghart, W.; Kolblinger, C.; Reiberger, T.; Li, S.; Ferlitsch, A.; Muller, C.; Lammer, J.; Peck-Radosavljevic, M. Hepatocellular carcinoma: A Phase II randomized controlled double-blind trial of transarterial chemoembolization in combination with biweekly intravenous administration of bevacizumab or a placebo. Radiology 2015, 277, 903–912. [CrossRef] [PubMed]
    • (2015) Radiology , vol.277 , pp. 903-912
    • Pinter, M.1    Ulbrich, G.2    Sieghart, W.3    Kolblinger, C.4    Reiberger, T.5    Li, S.6    Ferlitsch, A.7    Muller, C.8    Lammer, J.9    Peck-Radosavljevic, M.10
  • 139
    • 84961566836 scopus 로고    scopus 로고
    • Efficacy, safety, and potential biomarkers of sunitinib and transarterial chemoembolization (TACE) combination in advanced hepatocellular carcinoma (HCC): Phase II trial
    • Pokuri, V.K.; Tomaszewski, G.M.; Ait-Oudhia, S.; Groman, A.; Khushalani, N.I.; Lugade, A.A.; Thanavala, Y.; Ashton, E.A.; Grande, C.; Fetterly, G.J.; et al. Efficacy, safety, and potential biomarkers of sunitinib and transarterial chemoembolization (TACE) combination in advanced hepatocellular carcinoma (HCC): Phase II trial. Am. J. Clin. Oncol. 2018, 41, 332–338. [CrossRef] [PubMed]
    • (2018) Am. J. Clin. Oncol , vol.41 , pp. 332-338
    • Pokuri, V.K.1    Tomaszewski, G.M.2    Ait-Oudhia, S.3    Groman, A.4    Khushalani, N.I.5    Lugade, A.A.6    Thanavala, Y.7    Ashton, E.A.8    Grande, C.9    Fetterly, G.J.10
  • 140
    • 84891915708 scopus 로고    scopus 로고
    • Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial
    • Cheng, A.L.; Kang, Y.K.; Lin, D.Y.; Park, J.W.; Kudo, M.; Qin, S.; Chung, H.C.; Song, X.; Xu, J.; Poggi, G.; et al. Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial. J. Clin. Oncol. 2013, 31, 4067–4075. [CrossRef] [PubMed]
    • (2013) J. Clin. Oncol. , vol.31 , pp. 4067-4075
    • Cheng, A.L.1    Kang, Y.K.2    Lin, D.Y.3    Park, J.W.4    Kudo, M.5    Qin, S.6    Chung, H.C.7    Song, X.8    Xu, J.9    Poggi, G.10
  • 141
    • 78249288161 scopus 로고    scopus 로고
    • Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: Implication for antiangiogenic approach to hepatocellular carcinoma
    • Yau, T.; Chan, P.; Pang, R.; Ng, K.; Fan, S.T.; Poon, R.T. Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: Implication for antiangiogenic approach to hepatocellular carcinoma. Cancer 2010, 116, 5022–5029. [CrossRef] [PubMed]
    • (2010) Cancer , vol.116 , pp. 5022-5029
    • Yau, T.1    Chan, P.2    Pang, R.3    Ng, K.4    Fan, S.T.5    Poon, R.T.6
  • 142
    • 85041472350 scopus 로고    scopus 로고
    • Efficacy and Safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma: A prospective observation study
    • Yu, W.C.; Zhang, K.Z.; Chen, S.G.; Liu, W.F. Efficacy and Safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma: A prospective observation study. Medicine 2018, 97, e9704. [CrossRef] [PubMed]
    • (2018) Medicine , vol.97
    • Yu, W.C.1    Zhang, K.Z.2    Chen, S.G.3    Liu, W.F.4
  • 143
    • 85036543651 scopus 로고    scopus 로고
    • Apatinib is effective for treatment of advanced hepatocellular carcinoma
    • Kong, Y.; Sun, L.; Hou, Z.; Zhang, Y.; Chen, P.; Cui, Y.; Zhu, X.; Song, T.; Li, Q.; Li, H.; et al. Apatinib is effective for treatment of advanced hepatocellular carcinoma. Oncotarget 2017, 8, 105596–105605. [CrossRef] [PubMed]
    • (2017) Oncotarget , vol.8 , pp. 105596-105605
    • Kong, Y.1    Sun, L.2    Hou, Z.3    Zhang, Y.4    Chen, P.5    Cui, Y.6    Zhu, X.7    Song, T.8    Li, Q.9    Li, H.10
  • 144
    • 84920993186 scopus 로고    scopus 로고
    • Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trial
    • Cainap, C.; Qin, S.; Huang, W.T.; Chung, I.J.; Pan, H.; Cheng, Y.; Kudo, M.; Kang, Y.K.; Chen, P.J.; Toh, H.C.; et al. Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trial. J. Clin. Oncol. 2015, 33, 172–179. [CrossRef] [PubMed]
    • (2015) J. Clin. Oncol. , vol.33 , pp. 172-179
    • Cainap, C.1    Qin, S.2    Huang, W.T.3    Chung, I.J.4    Pan, H.5    Cheng, Y.6    Kudo, M.7    Kang, Y.K.8    Chen, P.J.9    Toh, H.C.10
  • 145
    • 84888001200 scopus 로고    scopus 로고
    • Exposure-response (Safety) analysis to identify linifanib dose for a Phase III study in patients with hepatocellular carcinoma
    • Chiu, Y.L.; Carlson, D.M.; Pradhan, R.S.; Ricker, J.L. Exposure-response (safety) analysis to identify linifanib dose for a Phase III study in patients with hepatocellular carcinoma. Clin. Ther. 2013, 35, 1770–1777. [CrossRef] [PubMed]
    • (2013) Clin. Ther. , vol.35 , pp. 1770-1777
    • Chiu, Y.L.1    Carlson, D.M.2    Pradhan, R.S.3    Ricker, J.L.4
  • 146
    • 84954621530 scopus 로고    scopus 로고
    • TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behcet’s syndrome refractory to the conventional treatment modalities: A case series and review of the literature
    • Hatemi, I.; Hatemi, G.; Pamuk, O.N.; Erzin, Y.; Celik, A.F. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behcet’s syndrome refractory to the conventional treatment modalities: A case series and review of the literature. Clin. Exp. Rheumatol. 2015, 33 (Suppl. 94), S129–S137. [PubMed]
    • (2015) Clin. Exp. Rheumatol , vol.33 , Issue.94 , pp. S129-S137
    • Hatemi, I.1    Hatemi, G.2    Pamuk, O.N.3    Erzin, Y.4    Celik, A.F.5
  • 147
    • 77949716939 scopus 로고    scopus 로고
    • Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways
    • Segarra, M.; Lozano, E.; Corbera-Bellalta, M.; Vilardell, C.; Cibeira, M.T.; Esparza, J.; Izco, N.; Blade, J.; Cid, M.C. Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways. Haematologica 2010, 95, 456–463. [CrossRef] [PubMed]
    • (2010) Haematologica , vol.95 , pp. 456-463
    • Segarra, M.1    Lozano, E.2    Corbera-Bellalta, M.3    Vilardell, C.4    Cibeira, M.T.5    Esparza, J.6    Izco, N.7    Blade, J.8    Cid, M.C.9
  • 148
    • 85021845807 scopus 로고    scopus 로고
    • Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: A systematic review and meta-analysis
    • Cao, D.D.; Xu, H.L.; Liu, L.; Zheng, Y.F.; Gao, S.F.; Xu, X.M.; Ge, W. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: A systematic review and meta-analysis. Oncotarget 2017, 8, 44976–44993. [CrossRef] [PubMed]
    • (2017) Oncotarget , vol.8 , pp. 44976-44993
    • Cao, D.D.1    Xu, H.L.2    Liu, L.3    Zheng, Y.F.4    Gao, S.F.5    Xu, X.M.6    Ge, W.7
  • 149
    • 84856051012 scopus 로고    scopus 로고
    • Sorafenib: Complexities of Raf-dependent and Raf-independent signaling are now unveiled
    • Matsuda, Y.; Fukumoto, M. Sorafenib: Complexities of Raf-dependent and Raf-independent signaling are now unveiled. Med. Mol. Morphol. 2011, 44, 183–189. [CrossRef] [PubMed]
    • (2011) Med. Mol. Morphol. , vol.44 , pp. 183-189
    • Matsuda, Y.1    Fukumoto, M.2
  • 150
    • 84873949249 scopus 로고    scopus 로고
    • Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
    • Gauthier, A.; Ho, M. Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update. Hepatol. Res. 2013, 43, 147–154. [CrossRef] [PubMed]
    • (2013) Hepatol. Res. , vol.43 , pp. 147-154
    • Gauthier, A.1    Ho, M.2
  • 151
    • 57349122313 scopus 로고    scopus 로고
    • Sorafenib in advanced hepatocellular carcinoma
    • Palmer, D.H. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 2008, 359, 378–390.
    • (2008) N. Engl. J. Med. , vol.359 , pp. 378-390
    • Palmer, D.H.1
  • 152
    • 85042088471 scopus 로고    scopus 로고
    • Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: A secondary analysis of a phase III study
    • Abdel-Rahman, O. Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: A secondary analysis of a phase III study. J. Cancer Res. Clin. Oncol. 2018, 144, 901–908. [CrossRef] [PubMed]
    • (2018) J. Cancer Res. Clin. Oncol. , vol.144 , pp. 901-908
    • Abdel-Rahman, O.1
  • 154
    • 84892979090 scopus 로고    scopus 로고
    • Recent developments of small molecule PI3K/mTOR dual inhibitors
    • Liu, Y.N.; Wan, R.Z.; Liu, Z.P. Recent developments of small molecule PI3K/mTOR dual inhibitors. Mini Rev. Med. Chem. 2013, 13, 2047–2059. [CrossRef] [PubMed]
    • (2013) Mini Rev. Med. Chem. , vol.13 , pp. 2047-2059
    • Liu, Y.N.1    Wan, R.Z.2    Liu, Z.P.3
  • 155
  • 157
    • 84964786369 scopus 로고    scopus 로고
    • Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)
    • Koeberle, D.; Dufour, J.F.; Demeter, G.; Li, Q.; Ribi, K.; Samaras, P.; Saletti, P.; Roth, A.D.; Horber, D.; Buehlmann, M.; et al. Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): A randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Ann. Oncol. 2016, 27, 856–861. [CrossRef] [PubMed]
    • (2016) Ann. Oncol. , vol.27 , pp. 856-861
    • Koeberle, D.1    Dufour, J.F.2    Demeter, G.3    Li, Q.4    Ribi, K.5    Samaras, P.6    Saletti, P.7    Roth, A.D.8    Horber, D.9    Buehlmann, M.10
  • 158
    • 0035395236 scopus 로고    scopus 로고
    • Ng, I.O. β-Catenin mutation and overexpression in hepatocellular carcinoma: Clinicopathologic and prognostic significance
    • Wong, C.M.; Fan, S.T.; Ng, I.O. β-Catenin mutation and overexpression in hepatocellular carcinoma: Clinicopathologic and prognostic significance. Cancer 2001, 92, 136–145. [CrossRef]
    • (2001) Cancer , vol.92 , pp. 136-145
    • Wong, C.M.1    Fan, S.T.2
  • 159
    • 84991063920 scopus 로고    scopus 로고
    • Direct targeting of beta-catenin by a small molecule stimulates proteasomal degradation and suppresses oncogenic Wnt/beta-catenin signaling
    • Hwang, S.Y.; Deng, X.; Byun, S.; Lee, C.; Lee, S.J.; Suh, H.; Zhang, J.; Kang, Q.; Zhang, T.; Westover, K.D.; et al. Direct targeting of beta-catenin by a small molecule stimulates proteasomal degradation and suppresses oncogenic Wnt/beta-catenin signaling. Cell Rep. 2016, 16, 28–36. [CrossRef] [PubMed]
    • (2016) Cell Rep , vol.16 , pp. 28-36
    • Hwang, S.Y.1    Deng, X.2    Byun, S.3    Lee, C.4    Lee, S.J.5    Suh, H.6    Zhang, J.7    Kang, Q.8    Zhang, T.9    Westover, K.D.10
  • 160
    • 26444584958 scopus 로고    scopus 로고
    • Nuclear factor-kappaB and liver carcinogenesis
    • Arsura, M.; Cavin, L.G. Nuclear factor-kappaB and liver carcinogenesis. Cancer Lett. 2005, 229, 157–169. [CrossRef] [PubMed]
    • (2005) Cancer Lett , vol.229 , pp. 157-169
    • Arsura, M.1    Cavin, L.G.2
  • 161
    • 84873282409 scopus 로고    scopus 로고
    • Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib
    • Wahl, K.; Siegemund, M.; Lehner, F.; Vondran, F.; Nussler, A.; Langer, F.; Krech, T.; Kontermann, R.; Manns, M.P.; Schulze-Osthoff, K.; et al. Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib. Hepatology 2013, 57, 625–636. [CrossRef] [PubMed]
    • (2013) Hepatology , vol.57 , pp. 625-636
    • Wahl, K.1    Siegemund, M.2    Lehner, F.3    Vondran, F.4    Nussler, A.5    Langer, F.6    Krech, T.7    Kontermann, R.8    Manns, M.P.9    Schulze-Osthoff, K.10
  • 163
    • 84873736254 scopus 로고    scopus 로고
    • Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities
    • Pardee, A.D.; Butterfield, L.H. Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities. Oncoimmunology 2012, 1, 48–55. [CrossRef] [PubMed]
    • (2012) Oncoimmunology , vol.1 , pp. 48-55
    • Pardee, A.D.1    Butterfield, L.H.2
  • 167
    • 85006324215 scopus 로고    scopus 로고
    • Spirodalesol, an NLRP3 Inflammasome Activation Inhibitor
    • Zhang, A.H.; Liu, W.; Jiang, N.; Xu, Q.; Tan, R.X. Spirodalesol, an NLRP3 Inflammasome Activation Inhibitor. Org. Lett. 2016, 18, 6496–6499. [CrossRef] [PubMed]
    • (2016) Org. Lett. , vol.18 , pp. 6496-6499
    • Zhang, A.H.1    Liu, W.2    Jiang, N.3    Xu, Q.4    Tan, R.X.5
  • 169
    • 84963795296 scopus 로고    scopus 로고
    • A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet
    • Yang, G.; Lee, H.E.; Lee, J.Y. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet. Sci. Rep. 2016, 6, 24399. [CrossRef] [PubMed]
    • (2016) Sci. Rep. , vol.6
    • Yang, G.1    Lee, H.E.2    Lee, J.Y.3
  • 172
    • 77955475968 scopus 로고    scopus 로고
    • NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses
    • Gris, D.; Ye, Z.; Iocca, H.A.; Wen, H.; Craven, R.R.; Gris, P.; Huang, M.; Schneider, M.; Miller, S.D.; Ting, J.P. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 2010, 185, 974–981. [CrossRef] [PubMed]
    • (2010) J. Immunol. , vol.185 , pp. 974-981
    • Gris, D.1    Ye, Z.2    Iocca, H.A.3    Wen, H.4    Craven, R.R.5    Gris, P.6    Huang, M.7    Schneider, M.8    Miller, S.D.9    Ting, J.P.10
  • 173
    • 84862988248 scopus 로고    scopus 로고
    • NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis
    • Inoue, M.; Williams, K.L.; Gunn, M.D.; Shinohara, M.L. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2012, 109, 10480–10485. [CrossRef] [PubMed]
    • (2012) Proc. Natl. Acad. Sci. USA , vol.109 , pp. 10480-10485
    • Inoue, M.1    Williams, K.L.2    Gunn, M.D.3    Shinohara, M.L.4
  • 174
    • 84861473687 scopus 로고    scopus 로고
    • Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome
    • Inoue, M.; Williams, K.L.; Oliver, T.; Vandenabeele, P.; Rajan, J.V.; Miao, E.A.; Shinohara, M.L. Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Sci. Signal. 2012, 5, ra38. [CrossRef] [PubMed]
    • (2012) Sci. Signal. , vol.5
    • Inoue, M.1    Williams, K.L.2    Oliver, T.3    Vandenabeele, P.4    Rajan, J.V.5    Miao, E.A.6    Shinohara, M.L.7
  • 176
    • 0033854015 scopus 로고    scopus 로고
    • Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer
    • Ikeda, K.; Arase, Y.; Saitoh, S.; Kobayashi, M.; Suzuki, Y.; Suzuki, F.; Tsubota, A.; Chayama, K.; Murashima, N.; Kumada, H. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000, 32, 228–232. [CrossRef] [PubMed]
    • (2000) Hepatology , vol.32 , pp. 228-232
    • Ikeda, K.1    Arase, Y.2    Saitoh, S.3    Kobayashi, M.4    Suzuki, Y.5    Suzuki, F.6    Tsubota, A.7    Chayama, K.8    Murashima, N.9    Kumada, H.10
  • 177
    • 0037080269 scopus 로고    scopus 로고
    • Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches
    • Sakon, M.; Nagano, H.; Dono, K.; Nakamori, S.; Umeshita, K.; Yamada, A.; Kawata, S.; Imai, Y.; Iijima, S.; Monden, M. Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 2002, 94, 435–442. [CrossRef] [PubMed]
    • (2002) Cancer , vol.94 , pp. 435-442
    • Sakon, M.1    Nagano, H.2    Dono, K.3    Nakamori, S.4    Umeshita, K.5    Yamada, A.6    Kawata, S.7    Imai, Y.8    Iijima, S.9    Monden, M.10
  • 178
    • 0035872948 scopus 로고    scopus 로고
    • Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial
    • Kubo, S.; Nishiguchi, S.; Hirohashi, K.; Tanaka, H.; Shuto, T.; Yamazaki, O.; Shiomi, S.; Tamori, A.; Oka, H.; Igawa, S.; et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann. Intern. Med. 2001, 134, 963–967. [CrossRef] [PubMed]
    • (2001) Ann. Intern. Med. , vol.134 , pp. 963-967
    • Kubo, S.1    Nishiguchi, S.2    Hirohashi, K.3    Tanaka, H.4    Shuto, T.5    Yamazaki, O.6    Shiomi, S.7    Tamori, A.8    Oka, H.9    Igawa, S.10
  • 179
    • 18644381723 scopus 로고    scopus 로고
    • Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma
    • Reinisch, W.; Holub, M.; Katz, A.; Herneth, A.; Lichtenberger, C.; Schoniger-Hekele, M.; Waldhoer, T.; Oberhuber, G.; Ferenci, P.; Gangl, A.; et al. Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinoma. J. Immunother. 2002, 25, 489–499. [CrossRef] [PubMed]
    • (2002) J. Immunother. , vol.25 , pp. 489-499
    • Reinisch, W.1    Holub, M.2    Katz, A.3    Herneth, A.4    Lichtenberger, C.5    Schoniger-Hekele, M.6    Waldhoer, T.7    Oberhuber, G.8    Ferenci, P.9    Gangl, A.10
  • 181
    • 84887427672 scopus 로고    scopus 로고
    • Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
    • Cui, J.; Wang, N.; Zhao, H.; Jin, H.; Wang, G.; Niu, C.; Terunuma, H.; He, H.; Li, W. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma. Int. J. Cancer 2014, 134, 342–351. [CrossRef] [PubMed]
    • (2014) Int. J. Cancer , vol.134 , pp. 342-351
    • Cui, J.1    Wang, N.2    Zhao, H.3    Jin, H.4    Wang, G.5    Niu, C.6    Terunuma, H.7    He, H.8    Li, W.9
  • 182
    • 84455162015 scopus 로고    scopus 로고
    • Hepatocellular carcinoma-specific immunotherapy with synthesized alpha1,3-galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells
    • Qiu, Y.; Xu, M.B.; Yun, M.M.; Wang, Y.Z.; Zhang, R.M.; Meng, X.K.; Ou-Yang, X.H.; Yun, S. Hepatocellular carcinoma-specific immunotherapy with synthesized alpha1,3-galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells. World J. Gastroenterol. 2011, 17, 5260–5266. [CrossRef] [PubMed]
    • (2011) World J. Gastroenterol. , vol.17 , pp. 5260-5266
    • Qiu, Y.1    Xu, M.B.2    Yun, M.M.3    Wang, Y.Z.4    Zhang, R.M.5    Meng, X.K.6    Ou-Yang, X.H.7    Yun, S.8
  • 183
    • 84979771531 scopus 로고    scopus 로고
    • Expanded and activated natural killer cells for immunotherapy of hepatocellular carcinoma
    • Kamiya, T.; Chang, Y.H.; Campana, D. Expanded and activated natural killer cells for immunotherapy of hepatocellular carcinoma. Cancer Immunol. Res. 2016, 4, 574–581. [CrossRef] [PubMed]
    • (2016) Cancer Immunol. Res. , vol.4 , pp. 574-581
    • Kamiya, T.1    Chang, Y.H.2    Campana, D.3
  • 184
    • 84863303647 scopus 로고    scopus 로고
    • Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: Immunologic evidence and potential for improving overall survival
    • Sawada, Y.; Yoshikawa, T.; Nobuoka, D.; Shirakawa, H.; Kuronuma, T.; Motomura, Y.; Mizuno, S.; Ishii, H.; Nakachi, K.; Konishi, M.; et al. Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: Immunologic evidence and potential for improving overall survival. Clin. Cancer Res. 2012, 18, 3686–3696. [CrossRef] [PubMed]
    • (2012) Clin. Cancer Res. , vol.18 , pp. 3686-3696
    • Sawada, Y.1    Yoshikawa, T.2    Nobuoka, D.3    Shirakawa, H.4    Kuronuma, T.5    Motomura, Y.6    Mizuno, S.7    Ishii, H.8    Nakachi, K.9    Konishi, M.10
  • 186
    • 84899978058 scopus 로고    scopus 로고
    • Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma
    • Chan, A.W.; Tong, J.H.; Chan, S.L.; Lai, P.B.; To, K.F. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma. Histopathology 2014, 64, 935–950. [CrossRef] [PubMed]
    • (2014) Histopathology , vol.64 , pp. 935-950
    • Chan, A.W.1    Tong, J.H.2    Chan, S.L.3    Lai, P.B.4    To, K.F.5
  • 190
    • 84884698526 scopus 로고    scopus 로고
    • The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
    • Shi, L.; Chen, S.; Yang, L.; Li, Y. The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies. J. Hematol. Oncol. 2013, 6, 74. [CrossRef] [PubMed]
    • (2013) J. Hematol. Oncol. , vol.6 , pp. 74
    • Shi, L.1    Chen, S.2    Yang, L.3    Li, Y.4
  • 191
    • 84901985040 scopus 로고    scopus 로고
    • The PD-1/PD-Ls pathway and autoimmune diseases
    • Dai, S.; Jia, R.; Zhang, X.; Fang, Q.; Huang, L. The PD-1/PD-Ls pathway and autoimmune diseases. Cell. Immunol. 2014, 290, 72–79. [CrossRef] [PubMed]
    • (2014) Cell. Immunol. , vol.290 , pp. 72-79
    • Dai, S.1    Jia, R.2    Zhang, X.3    Fang, Q.4    Huang, L.5
  • 193
    • 85018660134 scopus 로고    scopus 로고
    • Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, non-comparative, phase 1/2 dose escalation and expansion trial
    • El-Khoueiry, A.B.; Sangro, B.; Yau, T.; Crocenzi, T.S.; Kudo, M.; Hsu, C.; Kim, T.Y.; Choo, S.P.; Trojan, J.; Welling, T.H.R.; et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 2017, 389, 2492–2502. [CrossRef]
    • (2017) Lancet , vol.389 , pp. 2492-2502
    • El-Khoueiry, A.B.1    Sangro, B.2    Yau, T.3    Crocenzi, T.S.4    Kudo, M.5    Hsu, C.6    Kim, T.Y.7    Choo, S.P.8    Trojan, J.9    Welling, T.H.R.10
  • 194
    • 0037126021 scopus 로고    scopus 로고
    • Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
    • Iwai, Y.; Ishida, M.; Tanaka, Y.; Okazaki, T.; Honjo, T.; Minato, N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. USA 2002, 99, 12293–12297. [CrossRef] [PubMed]
    • (2002) Proc. Natl. Acad. Sci. USA , vol.99 , pp. 12293-12297
    • Iwai, Y.1    Ishida, M.2    Tanaka, Y.3    Okazaki, T.4    Honjo, T.5    Minato, N.6
  • 195
    • 85018630883 scopus 로고    scopus 로고
    • Transcriptional activation of PD-L1 by Sox2 contributes to the proliferation of hepatocellular carcinoma cells
    • Zhong, F.; Cheng, X.; Sun, S.; Zhou, J. Transcriptional activation of PD-L1 by Sox2 contributes to the proliferation of hepatocellular carcinoma cells. Oncol. Rep. 2017, 37, 3061–3067. [CrossRef] [PubMed]
    • (2017) Oncol. Rep. , vol.37 , pp. 3061-3067
    • Zhong, F.1    Cheng, X.2    Sun, S.3    Zhou, J.4
  • 196
    • 85022010830 scopus 로고    scopus 로고
    • Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma
    • Liu, J.; Liu, Y.; Meng, L.; Liu, K.; Ji, B. Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma. Oncol. Rep. 2017, 38, 899–907. [CrossRef] [PubMed]
    • (2017) Oncol. Rep. , vol.38 , pp. 899-907
    • Liu, J.1    Liu, Y.2    Meng, L.3    Liu, K.4    Ji, B.5
  • 197
    • 52349124048 scopus 로고    scopus 로고
    • Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice
    • Zhang, W.; Liu, J.; Wu, Y.; Xiao, F.; Wang, Y.; Wang, R.; Yang, H.; Wang, G.; Yang, J.; Deng, H.; et al. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice. Biochem. Biophys. Res. Commun. 2008, 376, 10–14. [CrossRef] [PubMed]
    • (2008) Biochem. Biophys. Res. Commun. , vol.376 , pp. 10-14
    • Zhang, W.1    Liu, J.2    Wu, Y.3    Xiao, F.4    Wang, Y.5    Wang, R.6    Yang, H.7    Wang, G.8    Yang, J.9    Deng, H.10
  • 200
    • 85019622453 scopus 로고    scopus 로고
    • Nifuroxazide prompts antitumor immune response of TCL-loaded DC in mice with orthotopically-implanted hepatocarcinoma
    • Zhao, T.; Jia, H.; Cheng, Q.; Xiao, Y.; Li, M.; Ren, W.; Li, C.; Feng, Y.; Feng, Z.; Wang, H.; et al. Nifuroxazide prompts antitumor immune response of TCL-loaded DC in mice with orthotopically-implanted hepatocarcinoma. Oncol. Rep. 2017, 37, 3405–3414. [CrossRef] [PubMed]
    • (2017) Oncol. Rep. , vol.37 , pp. 3405-3414
    • Zhao, T.1    Jia, H.2    Cheng, Q.3    Xiao, Y.4    Li, M.5    Ren, W.6    Li, C.7    Feng, Y.8    Feng, Z.9    Wang, H.10
  • 201
    • 84928827745 scopus 로고    scopus 로고
    • Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B-positive patients with hepatocellular carcinoma
    • Wang, X.; Bayer, M.E.; Chen, X.; Fredrickson, C.; Cornforth, A.N.; Liang, G.; Cannon, J.; He, J.; Fu, Q.; Liu, J.; et al. Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B-positive patients with hepatocellular carcinoma. J. Surg. Oncol. 2015, 111, 862–867. [CrossRef] [PubMed]
    • (2015) J. Surg. Oncol. , vol.111 , pp. 862-867
    • Wang, X.1    Bayer, M.E.2    Chen, X.3    Fredrickson, C.4    Cornforth, A.N.5    Liang, G.6    Cannon, J.7    He, J.8    Fu, Q.9    Liu, J.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.